| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A. B. Benson, III (ed)., Gastrointestinal oncology
|
P. Saletti
|
|
1999
|
10 |
9 |
p. 1130-1130
1 p.
|
artikel
|
| 2 |
Awards, appointments
|
|
|
|
10 |
9 |
p. 1003
|
artikel
|
| 3 |
Awareness of disease among Italian cancer patients: Is there a need for further improvement in patient information?
|
|
|
|
10 |
9 |
p. 1095-1100
|
artikel
|
| 4 |
Awareness of disease among Italian cancer patients: Is there a need forfurther improvement in patient information?
|
|
|
1999
|
10 |
9 |
p. 1095-1100
6 p.
|
artikel
|
| 5 |
Between Rosy Bindi and pyjamas
|
|
|
|
10 |
9 |
p. 1002-1003
|
artikel
|
| 6 |
Book review
|
Saletti, P.
|
|
|
10 |
9 |
p. 1130
|
artikel
|
| 7 |
Book review
|
Cavalli, F.
|
|
|
10 |
9 |
p. 1006
|
artikel
|
| 8 |
CHOP versus MACOP-B in aggressive lymphoma - a Nordic Lymphoma Group randomised trial
|
Jerkeman, M.
|
|
|
10 |
9 |
p. 1079-1086
|
artikel
|
| 9 |
Chop Versus Macop-b in Aggressive Lymphoma a Nordic Lymphoma Group Randomised Trial
|
M. Jerkeman
|
|
1999
|
10 |
9 |
p. 1079-1086
8 p.
|
artikel
|
| 10 |
Complete response of a gastric primary after a short but toxic course of ‘S-1’
|
Schöffski, P.
|
|
|
10 |
9 |
p. 1117-1120
|
artikel
|
| 11 |
Complete response of a gastric primary after a short but toxic course ofS-1
|
P. Schöffski
|
|
1999
|
10 |
9 |
p. 1117-1120
4 p.
|
artikel
|
| 12 |
Contents of the next issue
|
|
|
|
10 |
9 |
p. vi
|
artikel
|
| 13 |
Copyright
|
|
|
|
10 |
9 |
p. iv
|
artikel
|
| 14 |
Council of Europe criticizes euthanasia
|
|
|
|
10 |
9 |
p. 1002
|
artikel
|
| 15 |
David Kerr new Editor-in-Chief of Annals of Oncology
|
|
|
|
10 |
9 |
p. 1001
|
artikel
|
| 16 |
David Kerr new Editor-in-Chief of Annals of Oncology; How muchdo trials cost?; Council of Europe criticizes euthanasia; Between Rosy Bindiand pyjamas; Awards, appointments; Perhaps not everyone knows that...
|
|
|
1999
|
10 |
9 |
p. 1001-1005
5 p.
|
artikel
|
| 17 |
Editorial Board
|
|
|
|
10 |
9 |
p. v
|
artikel
|
| 18 |
Factors associated with tumor volume and primary metastases in Ewing tumors: Results from the (EI)CESS studies
|
Hense, H.W.
|
|
|
10 |
9 |
p. 1073-1078
|
artikel
|
| 19 |
Factors associated with tumor volume and primary metastases in Ewingtumors: Results from the (EI)CESS studies
|
H. W. Hense
|
|
1999
|
10 |
9 |
p. 1073-1077
5 p.
|
artikel
|
| 20 |
High-dose methotrexate and HELP [Holoxan (ifosfamide), Eldesine (vindesine), platinum] - doxorubicin in non-metastatic osteosarcoma of the extremity: A French multicentre pilot study
|
Philip, T.
|
|
|
10 |
9 |
p. 1065-1072
|
artikel
|
| 21 |
High-dose methotrexate and HELP [Holoxan (ifosfamide), Eldesine(vindesine), platinum] doxorubicin in non-metastatic osteosarcoma ofthe extremity: A French multicentre pilot study
|
T. Philip
|
|
1999
|
10 |
9 |
p. 1065-1071
7 p.
|
artikel
|
| 22 |
How much do trials cost?
|
|
|
|
10 |
9 |
p. 1001
|
artikel
|
| 23 |
In this issue
|
|
|
|
10 |
9 |
p. vi
|
artikel
|
| 24 |
Life threatening laryngeal toxicity following treatment with combined chemoradiotherapy for nasopharyngeal cancer: A case report with review of the literature
|
Baron-Hay, S.
|
|
|
10 |
9 |
p. 1109-1112
|
artikel
|
| 25 |
Life threatening laryngeal toxicity following treatment with combinedchemoradiotherapy for nasopharyngeal cancer: A case report with review of theliterature
|
S. Baron-Hay
|
|
1999
|
10 |
9 |
p. 1109-1112
4 p.
|
artikel
|
| 26 |
Little to learn from phase II trials in small-cell lung cancer
|
Leyvraz, S.
|
|
|
10 |
9 |
p. 1007-1009
|
artikel
|
| 27 |
Little to learn from phase II trials in small-cell lung cancer
|
S. Leyvraz
|
|
1999
|
10 |
9 |
p. 1007-1009
3 p.
|
artikel
|
| 28 |
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: Prolonged intrathoracic tumor control and high central nervous system relapse rate
|
van de Velde, H.
|
|
|
10 |
9 |
p. 1051-1058
|
artikel
|
| 29 |
Moderate dose-escalation of combination chemotherapy with concomitantthoracic radiotherapy in limited-disease small-cell lung cancer: Prolongedintrathoracic tumor control and high central nervous system relapse rate
|
H. van de Velde
|
|
1999
|
10 |
9 |
p. 1051-1057
7 p.
|
artikel
|
| 30 |
Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: An investigator-originated compassionate-use experience
|
Faivre, S.
|
|
|
10 |
9 |
p. 1125-1128
|
artikel
|
| 31 |
Oxaliplatin and paclitaxel combination in patients withplatinum-pretreated ovarian carcinoma: An investigator-originatedcompassionate-use experience
|
S. Faivre
|
|
1999
|
10 |
9 |
p. 1125-1128
4 p.
|
artikel
|
| 32 |
Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-cell lung cancer
|
Sørensen, J.B.
|
|
|
10 |
9 |
p. 1043-1050
|
artikel
|
| 33 |
Paclitaxel, gemcitabine, and cisplatin in non-resectable non-small-celllung cancer
|
J. B. Sørensen
|
|
1999
|
10 |
9 |
p. 1043-1049
7 p.
|
artikel
|
| 34 |
p53 and chemosensitivity
|
Ferreira, C.G.
|
|
|
10 |
9 |
p. 1011-1022
|
artikel
|
| 35 |
p53 and chemosensitivity
|
C. G. Ferreira
|
|
1999
|
10 |
9 |
p. 1011-1021
11 p.
|
artikel
|
| 36 |
Perhaps not everyone knows that…
|
|
|
|
10 |
9 |
p. 1003-1005
|
artikel
|
| 37 |
Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer
|
Isokangas, O.-P.
|
|
|
10 |
9 |
p. 1059-1064
|
artikel
|
| 38 |
Phase II study of vinorelbine and gemcitabine for inoperable stageIIIBIV non-small-cell lung cancer
|
O.-P. Isokangas
|
|
1999
|
10 |
9 |
p. 1059-1063
5 p.
|
artikel
|
| 39 |
Phase I study of Doxil and vinorelbine in metastatic breast cancer
|
Burstein, H.J.
|
|
|
10 |
9 |
p. 1113-1116
|
artikel
|
| 40 |
Phase I study of Doxil and vinorelbine in metastatic breast cancer
|
H. J. Burstein
|
|
1999
|
10 |
9 |
p. 1113-1116
4 p.
|
artikel
|
| 41 |
Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites
|
Zucca, E.
|
|
|
10 |
9 |
p. 1023-1034
|
artikel
|
| 42 |
Primary extranodal non-Hodgkins lymphomas.Part 2: Head and neck, central nervous system and other less commonsites
|
E. Zucca
|
|
1999
|
10 |
9 |
p. 1023-1033
11 p.
|
artikel
|
| 43 |
Radiation myositis
|
Welsh, J.S.
|
|
|
10 |
9 |
p. 1105-1108
|
artikel
|
| 44 |
Radiation myositis
|
J. S. Welsh
|
|
1999
|
10 |
9 |
p. 1105-1108
4 p.
|
artikel
|
| 45 |
Recurrent inflammation in a site of previous necrotising fasciitis during intravenous CMF chemotherapy
|
Mackay, H.J.
|
|
|
10 |
9 |
p. 1101-1103
|
artikel
|
| 46 |
Recurrent inflammation in a site of previous necrotising fasciitis duringintravenous CMF chemotherapy
|
H. J. Mackay
|
|
1999
|
10 |
9 |
p. 1101-1103
3 p.
|
artikel
|
| 47 |
Risk of second cancer after testicular cancer in Vaud and Neuchâtel, Switzerland
|
Levi, F.
|
|
|
10 |
9 |
p. 1129-1130
|
artikel
|
| 48 |
Risk of second cancer after testicular cancer in Vaud andNeuchâtel, Switzerland
|
F. Levi
|
|
1999
|
10 |
9 |
p. 1129-1130
2 p.
|
artikel
|
| 49 |
R. N. Proctor (ed)., The Nazi war on cancer
|
F. Cavalli
|
|
1999
|
10 |
9 |
p. 1006-1006
1 p.
|
artikel
|
| 50 |
Saturable metabolism of continuous high-dose ifosfamide with Mesna and GM-CSF: A pharmacokinetic study in advanced sarcoma patients
|
Cerny, T.
|
|
|
10 |
9 |
p. 1087-1094
|
artikel
|
| 51 |
Saturable metabolism of continuous high-dose ifosfamide with Mesna andGM-CSF: A pharmacokinetic study in advanced sarcoma patients
|
T. Cerny
|
|
1999
|
10 |
9 |
p. 1087-1094
8 p.
|
artikel
|
| 52 |
Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers
|
Feuer, D.J.
|
|
|
10 |
9 |
p. 1035-1042
|
artikel
|
| 53 |
Systematic review and meta-analysis of corticosteroids for the resolutionof malignant bowel obstruction in advanced gynaecological and gastrointestinalcancers
|
D. J. Feuer
|
|
1999
|
10 |
9 |
p. 1035-1041
7 p.
|
artikel
|
| 54 |
Table of Contents
|
|
|
|
10 |
9 |
p. iii-iv
|
artikel
|
| 55 |
The clinical utility of the Revised European-American Lymphoma (R.E.A.L.) Classification: Preliminary results of a prospective study in patients with non-Hodgkin's lymphoma from a single centre
|
Sweetenham, J.W.
|
|
|
10 |
9 |
p. 1121-1124
|
artikel
|
| 56 |
The clinical utility of the Revised EuropeanAmerican Lymphoma(R.E.A.L.) Classification: Preliminary results of a prospective study inpatients with non-Hodgkins lymphoma from a single centre
|
J. W. Sweetenham
|
|
1999
|
10 |
9 |
p. 1121-1124
4 p.
|
artikel
|
Tijdschrift beschrijving